Search

everythinglearnresearchcommunity

for

Search:↓

Early balding in young Indian men may indicate a higher risk of metabolic syndrome and potential heart disease.

Multimodal minoxidil microemulsion is more effective in treating hair loss than minoxidil alone.

Androgens, male hormones, play a role in both men and women's health, and testosterone therapy can help women with low levels, but it's not suitable for pregnant or lactating women, or those with certain conditions.

Androgenic steroids can slow down or stop the growth of certain skin fungi.

People with hair loss may have different levels of certain hormones due to changes in hormone processing.

NTF gel improves finasteride delivery for hair loss treatment, reducing side effects.

Androgenetic alopecia is mainly caused by genetic factors and increased androgen activity, leading to hair follicle miniaturization.

Botulinum toxin was found to be a safe and effective treatment for male pattern baldness in a small test, but more research is needed.

Minoxidil can reduce functions related to androgen receptors.

Finasteride reverses early hair loss and promotes growth.

Women with androgenetic alopecia experience worse physical well-being and quality of life, but similar mental health compared to those without it.

Platelet-Rich Plasma (PRP) is a low-risk treatment for Androgenic Alopecia (AGA) that generally improves hair count or density, but more research is needed for optimization.

Hair loss in men and women is linked to high stress hormone levels and other hormonal imbalances, suggesting treatments should be customized to each person's hormones.

Sex hormones affect hair and feather growth and may help manage alopecia and hormone-dependent cancers.

DHT stops hair regrowth in mice, similar to human hair loss.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

Both androgenetic alopecia and alopecia areata negatively impact quality of life, with no significant difference between them.

Topical finasteride reduces hair loss and promotes hair growth in men and women.

Overweight women with PCOS are more likely to have excess male hormones.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

AR gene not major factor in female hair loss; different from male hair loss.

Both Platelet-Rich Plasma and Minoxidil foam increase hair count in women with hair loss, but Minoxidil is more effective. However, women were more satisfied with Platelet-Rich Plasma treatment.

Stem cell technologies and regenerative medicine, including platelet-rich plasma, show promise for hair restoration in treating hair loss, but more research is needed.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

Newer low-dose oral contraceptives with less androgenic effects improve patient compliance.

Androgen measurement helps diagnose PCOS, but accuracy varies, needing standard methods.

Androgens affect bone and fat cell development differently based on the cells' embryonic origin.

A woman had both Graham Little-Piccardi-Lassueur syndrome, causing hair loss, and complete androgen insensitivity syndrome, making her genetically male but physically female. This suggests androgens don't affect the hair loss condition.

Treatments for common hair loss include minoxidil, finasteride, and hair transplantation.

Hair loss from genetics and hormones can be treated with drugs or surgery.